Comparison of clinical outcomes of oral erythroleukoplakia treated with photodynamic therapy using either light‐emitting diode or laser light
Authors:
- Hung‐Pin LinHLHung‐Pin Lin
- Hsin‐Ming ChenHCHsin‐Ming Chen
- Hsiang YangHYHsiang Yang
- Yi‐Ping WangYWYi‐Ping Wang
- Chun‐Pin ChiangCCChun‐Pin Chiang
- 8 October 2009
- journal article
- clinical trial
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 41 (9) , 628-633
Abstract
Background and Objectives: Topical 5‐aminolevulinic acid‐mediated photodynamic therapy (topical ALA‐PDT) using a 635‐nm light‐emitting diode (LED) light is an effective treatment modality for oral verrucous hyperplasia. This study tested whether topical ALA‐PDT using either the LED or laser light was also an effective treatment modality for oral erythroleukoplakia (OEL) lesions.Study Design/Materials and Methods: In this prospective but non‐randomized study, 20 OEL lesions were treated with topical ALA‐PDT using the 635‐nm LED light and 26 OEL lesions were treated with topical ALA‐PDT using the 635‐nm laser light. The difference in clinical outcomes was compared between the two groups by Fisher exact test.Results: We found that the 20 LED light‐treated OEL lesions showed complete response (CR) in 17 and partial response (PR) in 3. The 17 CR OEL lesions required an average of 3.7 (range, 2–7) treatments of ALA‐PDT to achieve CR of the lesions. The 26 laser light‐treated OEL lesions showed CR in 25 and PR in 1. The 25 CR OEL lesions needed an average of 3.3 (range, 2–6) treatments of ALA‐PDT to achieve CR of the lesions. There was no significant difference in PDT outcomes between the 20 LED light‐treated and 26 laser light‐treated OEL lesions (P = 0.303). When the 42 CR OEL lesions were pooled together, we found that smaller lesions (greatest diameter P = 0.000) and lesions with thicker surface keratin (P = 0.000), respectively.Conclusions: Topical ALA‐PDT using either the LED or laser light is an effective treatment modality for OEL lesions. There is no significant difference in clinical outcomes of OEL lesions treated with PDT using either the LED or laser light. Lasers Surg. Med. 41:628–633, 2009.Keywords
Funding Information
- NATIONAL SCIENCE COUNCIL, Taipei, Taiwan (96-2628-B-002-060-MY3)
This publication has 13 references indexed in Scilit:
- The effect of betel quid and cigarette on multistate progression of oral pre‐malignancyJournal of Oral Pathology & Medicine, 2008
- Dose-response relationships of oral habits associated with the risk of oral pre-malignant lesions among men who chew betel quidOral Oncology, 2007
- Topical 5-aminolevulinic acid-mediated photodynamic therapy for oral verrucous hyperplasia, oral leukoplakia and oral erythroleukoplakiaPhotodiagnosis and Photodynamic Therapy, 2007
- Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapyLasers in Surgery and Medicine, 2005
- Successful treatment of oral verrucous hyperplasia with topical 5-aminolevulinic acid-mediated photodynamic therapyOral Oncology, 2004
- Photodynamic Therapy of oral dysplasia with topical 5‐aminolevulinic acid and light‐emitting diode arrayLasers in Surgery and Medicine, 2004
- Photodynamic therapy for cancerNature Reviews Cancer, 2003
- Photodynamic Therapy (PDT) and Photodiagnosis (PD) Using Endogenous Photosensitization Induced by 5-Aminolevulinic Acid (ALA): Mechanisms and Clinical ResultsJournal of Clinical Laser Medicine & Surgery, 1996
- Photodynamic therapy with endogenous protoporphyrinJournal of Photochemistry and Photobiology B: Biology, 1990
- Surgical treatment of premalignant lesions of the oral mucosaInternational Journal of Oral and Maxillofacial Surgery, 1987